Related Experiment Videos
Cardiovascular aspects in renal disease
1Department of Internal Medicine, University Hospital, Maastricht, The Netherlands.
Insights
Cardiovascular disease is the main cause of death in hemodialysis patients. Managing hypertension, anemia, and fluid overload is crucial for improving outcomes and reducing mortality in these patients.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Cardiovascular disease is the leading cause of mortality in hemodialysis patients.
- Coronary artery disease is prevalent, but myocardial infarction contributes less to mortality than expected.
- Hypertension and lipid abnormalities are common risk factors in uremic patients.
Purpose of the Study:
- To investigate the risk factors and mechanisms contributing to cardiovascular mortality in hemodialysis patients.
- To highlight the role of left ventricular hypertrophy and dysfunction in hemodialysis-associated morbidity and mortality.
Main Methods:
- Review of existing literature on cardiovascular disease in hemodialysis patients.
- Analysis of risk factors including hypertension, dyslipidemia, anemia, and fluid overload.
- Examination of the pathophysiology of left ventricular hypertrophy and its clinical implications.
Main Results:
- Hypertension is a major driver of atherosclerosis in hemodialysis patients.
- Left ventricular hypertrophy is a significant risk factor for morbidity and mortality.
- Systolic and diastolic left ventricular dysfunction can result from various factors including anemia, hypercirculation, and uremic changes.
Conclusions:
- Early correction of anemia and adequate treatment of hypertension are essential in renal failure.
- Prevention of chronic fluid overload through accurate dry weight estimation is critical.
- Comprehensive management of cardiovascular risk factors is vital for improving survival in hemodialysis patients.
Abstract:
The majority of hemodialysis patients die from cardiovascular disease. However, the contribution of myocardial infarction to mortality is relatively minor, despite the fact that coronary artery disease is common in uremic patients. Hypertension seems to be the major risk factor for the development of atherosclerosis in hemodialysis patients, although abnormalities of the lipid spectrum, characterized by an increase in triglycerides and very low density lipoprotein levels and a decrease in high-density lipoprotein levels, are frequent in hemodialysis patients. The existence of left ventricular (LV) hypertrophy is a serious risk factor for morbidity and mortality in hemodialysis patients. LV hypertrophy can present as a dilated cardiomyopathy or as concentric or asymmetric septal hypertrophy. Loss of myocardial contractility by coronary artery disease or carnitine deficiency can lead to systolic LV dysfunction with a compensatory dilated cardiomyopathy. Furthermore, the presence of a hypercirculation in uremic patients, resulting from anemia, the arteriovenous fistula, or fluid overload, can also lead to a dilated cardiomyopathy. Systolic LV dysfunction occurs when the increase in LV wall thickness is inadequate for the increase in LV radius, which might be caused by increased levels of parathyroid hormone. LV diastolic dysfunction, resulting from an increase in LV mass due to the effects of hypertension or to uremic interstitial fibrosis, can both lead to pulmonary edema and hypotensive periods during hemodialysis and is a severe risk factor for mortality in hemodialysis patients. Therefore, in uremic patients, anemia should be corrected and hypertension adequately treated early in the development of renal failure. Chronic fluid overload should be prevented by adequate estimation of optimal dry weight.(ABSTRACT TRUNCATED AT 250 WORDS)